The introduction of a new generic medication to prevent the spread of HIV improves affordability – but only if plan sponsors encourage use and adherence.

Accredo pharmacist Janet Kohli, who specializes in supporting patients with advanced pulmonary conditions, shares how she guides patients through complex therapies with empathy, expertise, and coordinated, personalized support.

Bills currently moving through the Tennessee state legislature could cut off access to medicine for families, active-duty military members and more, while disrupting care for more than 180,000 Tennesseans. 

A $0 copayment makes it easier for military families living far from military facilities to get the medications they need.

Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology

As new cancer diagnosis shifts toward younger working‑age employees, employers need updated approaches to upstream prevention, early detection, benefit design, care navigation, and survivorship support.

As the gene and cell therapy pipeline continues to grow, Evernorth Health Services is enabling drug manufacturers, providers, and payers to work together to bring therapies to people who need them.

Explore how digital enablement can close gaps in hemophilia care and empower plan sponsors to deliver more connected, equitable support for members.

The promise and challenges of semaglutide, a new therapy for weight loss